Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Cementos Bio-Bio's Debt-to-EBITDA or its related term are showing as below:
XSGO:CEMENTOS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.44 Med: 3.74 Max: 6.44
Current: 2.44
During the past 13 years, the highest Debt-to-EBITDA Ratio of Cementos Bio-Bio was 6.44. The lowest was 2.44. And the median was 3.74.
XSGO:CEMENTOS's Debt-to-EBITDA is not ranked
in the Building Materials industry.
Industry Median: 2.27
vs XSGO:CEMENTOS: 2.44
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Cementos Bio-Bio Debt-to-EBITDA Related Terms
Cementos Bio-Bio Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Cementos Bio-Bio's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSGO:CEMENTOS vs CRH, VMC, MLM: Debt-to-EBITDA Comparison
For the Building Materials subindustry, Cementos Bio-Bio's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cementos Bio-Bio Debt-to-EBITDA vs Building Materials Industry
For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cementos Bio-Bio's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Dec. 2025) EBITDA data.
Cementos Bio-Bio (XSGO:CEMENTOS) has a Debt-to-EBITDA of 1.78 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Cementos Bio-Bio. This is 52% below median its historical median of 3.74. Over the past decade, Cementos Bio-Bio's Debt-to-EBITDA has ranged from 2.44 to 6.44.
Is Cementos Bio-Bio's Debt-to-EBITDA too high?
Cementos Bio-Bio's current Debt-to-EBITDA of 1.78 is 52% below median its 10-year median of 3.74. Over the past 10 years, this metric has ranged from a low of 2.44 to a high of 6.44. The Building Materials industry median Debt-to-EBITDA is 2.27. Cementos Bio-Bio's value of 1.78 is 21.6% below this industry median. Overall, Cementos Bio-Bio has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's Debt-to-EBITDA compare to CRH and VMC?
Cementos Bio-Bio's Debt-to-EBITDA of 1.78 can be compared against companies in the Building Materials industry. The industry median Debt-to-EBITDA is 2.27. Cementos Bio-Bio's value of 1.78 is 21.6% below this benchmark. Historically, Cementos Bio-Bio's own Debt-to-EBITDA has ranged from 2.44 to 6.44 over the past decade. While the company's 10-year median is 3.74 vs. the industry median of 2.27, Cementos Bio-Bio has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Building Materials company?
The median Debt-to-EBITDA among Building Materials companies is 2.27, based on 333 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cementos Bio-Bio's current Debt-to-EBITDA of 1.78 is 21.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Cementos Bio-Bio. For the Building Materials industry, the median Debt-to-EBITDA is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cementos Bio-Bio's current Debt-to-EBITDA is 1.78, which is 52% below median its own 10-year median of 3.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Cementos Bio-Bio (XSGO:CEMENTOS) has a current Debt-to-EBITDA of 1.78. The stock's GF Value™ is CLP742.22, compared to a current price of CLP1,730.00 — trading 133.1% above its estimated fair value. The current Debt-to-EBITDA is 1.78, which is 52% below median its 10-year median of 3.74 and 21.6% below the Building Materials industry median of 2.27. Cementos Bio-Bio's overall GF Score™ is 34/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current Debt-to-EBITDA is 1.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?
Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued.
The current stock price of CLP1,730.00 is trading 133.1% above its estimated GF Value™ of CLP742.22.
Key valuation signals for XSGO:CEMENTOS:
Debt-to-EBITDA: 1.78 (52% below median its 10-year median of 3.74)
GF Value™: CLP742.22 vs. price of CLP1,730.00 (133.1% above fair value)
Industry Position: 21.6% below the Building Materials median
No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSGO:CEMENTOS has been successfully added to your 
